TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organig

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Company”) today announ

Sanity Group integration marks the next phase of Organigram’s global growth strategyFinn Age Hänsel

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Comp

OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estima

Organigram Global NASDAQ: OGI reported record third-quarter fiscal 2026 revenue and adjusted EBITDA,

Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's

OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $76.413 million which beat the analyst

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Cana

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

Organigram's disappointing Q2 earnings could be a direct result of its record harvests overwhelming

Organigram Global Inc. (OGI:CA) Q2 2026 Earnings Call Transcript

Organigram Global Inc. (NASDAQ:OGI) reported weaker second-quarter fiscal 2026 results as declining

Organigram reports weak Q2 fiscal 2026 results due to vape and pre-roll sales decline, but expects i

OrganiGram (OGI) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus

Organigram Global NASDAQ: OGI reported a weaker second quarter for fiscal 2026, with management attr

OrganiGram Holdings (NASDAQ:OGI) reported quarterly losses of $(0.01) per share which met the analys

OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $43.597 million which missed the analys

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

TORONTO & BERLIN--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” o

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

Organigram Global Inc. (OGI:CA) Shareholder/Analyst Call Prepared Remarks Transcript

Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a le

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organi

This launch reflects Organigram's focus on differentiated innovation while leveraging the scale

Organigram Global Inc. ("Organigram" or the "Company") today announced the expansion

Organigram Global Inc. (OGI) shares rose after a $65.2 million private placement investment from Bri

Organigram stock surges after announcing proposed acquisition of Sanity Group, aiming to establish a

Accretive Acquisition of Sanity Group Establishes Organigram as a Global Pure Play Cannabis Company

https://www.marijuanamoment.net/trumps-marijuana-executive-order-details-leaked-ahead-of-announcemen

Trump is expected to sign an executive order reclassifying cannabis to Schedule III, easing federal

https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?i

OrganiGram Holdings (NASDAQ:OGI) reported quarterly losses of $(0.20) per share which missed the ana

Investors are prepping for this week's earnings reports which include homebuilders, several appa

The stock prices of major cannabis companies like skyrocketed n premarket trading on Friday, followi

President Donald Trump is reportedly planning to advocate for a significant relaxation of federal re